Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fisher Scientific International

This article was originally published in The Gray Sheet

Executive Summary

Files registration statement with the Securities and Exchange Commission relating to a proposed offering of $125 mil. in step-up convertible subordinated notes due in 2003. The research and testing product manufacturer plans to use $40 mil. of anticipated proceeds to repay outstanding debt related to its Dec. 31 acquisition of the Hamilton Division of Hamilton Industries; the division manufactures laboratory systems and equipment. The balance of proceeds will be used for general corporate purposes, "including working capital, capital expenditures and potential acquisitions." Underwriting the offering are The First Boston Co.; BT Securities; Donaldson, Lufkin & Jenrette; Lazard Freres; and Smith Barney, Harris Upham.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000287

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel